Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-071553
Filing Date
2010-03-30
Accepted
2010-03-30 16:30:54
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 811398
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 2068
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9729
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9701
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3445
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3472
  Complete submission text file 0001193125-10-071553.txt   841325
Mailing Address 20245 SW 95TH AVENUE TUALATIN OR 97062
Business Address 20245 SW 95TH AVENUE TUALATIN OR 97062 5036928001
BIOJECT MEDICAL TECHNOLOGIES INC (Filer) CIK: 0000810084 (see all company filings)

EIN.: 931099680 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15360 | Film No.: 10714226
SIC: 3841 Surgical & Medical Instruments & Apparatus